A Murine Model of Waning Scrub Typhus Cross-Protection between Heterologous Strains of Orientia tsutsugamushi

• Published in: Pathogens (Basel) Vol. 11; no. 5; p. 512
• Main Authors: Mendell, Nicole L, Xu, Guang, Shelite, Thomas R, Bouyer, Donald H, Walker, David H
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.04.2022; MDPI
• Subjects: Animal models; Antibodies; Body weight; Body weight loss; Cross-protection; Erythema; Etiology; Fatalities; hematogenous model; Homology; Illnesses; Immune response; Immune system; Immunity; Infections; intradermal; Kidneys; Laboratories; Lethal dose; Organs; Orientia; Orientia tsutsugamushi; Pathogens; Scrub typhus; Spleen; Strains (organisms); sublethal; Typhus; Vaccines; Weight loss; sublethal; hematogenous model; immunity; Orientia; cross-protection; intradermal; scrub typhus
• ISSN: 2076-0817; 2076-0817
• DOI: 10.3390/pathogens11050512

, the etiologic agent of the life-threatening febrile disease scrub typhus, is an obligately intracellular small coccobacillary bacterium belonging to the family Rickettsiaceae and is transmitted by the parasitic larval stage of trombiculid mites. Progress towards a vaccine for protection against scrub typhus has been impeded by characteristics of the pathogen and the infection. There are numerous strains of in the Asia-Pacific region with geographical overlap. In human cases immunity has been described as poor against heterologous strains of the pathogen, as well as short-lived against the homologous strain, with a mean antibody reversion rate of less than one year. Animal models of cross-protection as well as of deterioration of this cross-protection are needed to enhance understanding of transient immunity to scrub typhus. To build upon current understanding of this ineffective protection we sought to utilize our recently developed models, sublethal intradermal infection followed by challenge via ordinarily lethal hematogenous dissemination. Mice that were initially infected sublethally with Gilliam strain and were challenged with an ordinarily lethal dose of heterologous Karp strain were protected from death by a robust immune response at one month after the primary infection as evidenced by an abundance of mononuclear cellular infiltrates in target organs such as lung, liver, and kidney; maintenance of body weight; and low bacterial loads in the organs. Waning protection from lethal Karp strain challenge indicated by weight loss mirroring that observed in naïve mice was observed as early as 9 months after primary Gilliam strain infection, and higher bacterial loads, severe disease, and eventual death in some mice was observed after challenge with Karp strain at 14 months post-initial heterologous infection.